Colgate-Palmolive (India) Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Colgate-Palmolive (India) wird ein jährliches Gewinn- und Umsatzwachstum von 9.2% bzw. 7.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 9.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 86% betragen.
Wichtige Informationen
10.6%
Wachstumsrate der Gewinne
10.7%
EPS-Wachstumsrate
| Personal Products Gewinnwachstum | 16.7% |
| Wachstumsrate der Einnahmen | 8.6% |
| Zukünftige Eigenkapitalrendite | 80.8% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 27 Sep 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Subdued Growth No Barrier To Colgate-Palmolive (India) Limited's (NSE:COLPAL) Price
Sep 10
Here's Why We Think Colgate-Palmolive (India) (NSE:COLPAL) Is Well Worth Watching
Jun 14Colgate-Palmolive (India)'s (NSE:COLPAL) Solid Profits Have Weak Fundamentals
May 22Colgate-Palmolive (India)'s (NSE:COLPAL) Upcoming Dividend Will Be Larger Than Last Year's
May 21Colgate-Palmolive (India) (NSE:COLPAL) Seems To Use Debt Rather Sparingly
Mar 23Colgate-Palmolive (India) Limited's (NSE:COLPAL) Price Is Out Of Tune With Earnings
Feb 15Do Colgate-Palmolive (India)'s (NSE:COLPAL) Earnings Warrant Your Attention?
Nov 23Colgate-Palmolive (India) (NSE:COLPAL) Is Paying Out A Larger Dividend Than Last Year
Oct 29Colgate-Palmolive (India) (NSE:COLPAL) Ticks All The Boxes When It Comes To Earnings Growth
Aug 17Does Colgate-Palmolive (India) (NSE:COLPAL) Have A Healthy Balance Sheet?
Jul 29Is Colgate-Palmolive (India) (NSE:COLPAL) A Risky Investment?
Feb 08Is Colgate-Palmolive (India) (NSE:COLPAL) A Risky Investment?
Aug 03Estimating The Intrinsic Value Of Colgate-Palmolive (India) Limited (NSE:COLPAL)
May 31Does Colgate-Palmolive (India) (NSE:COLPAL) Have A Healthy Balance Sheet?
Feb 10Colgate-Palmolive (India) (NSE:COLPAL) Will Pay A Larger Dividend Than Last Year At ₹19.00
Oct 27Is Colgate-Palmolive (India) (NSE:COLPAL) Using Too Much Debt?
Aug 30Do Institutions Own Colgate-Palmolive (India) Limited (NSE:COLPAL) Shares?
Mar 10Is Colgate-Palmolive (India) Limited's (NSE:COLPAL) Latest Stock Performance Being Led By Its Strong Fundamentals?
Feb 17Are Colgate-Palmolive (India)'s (NSE:COLPAL) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 27If You Had Bought Colgate-Palmolive (India) (NSE:COLPAL) Shares Five Years Ago You'd Have Earned 76% Returns
Jan 09
Could Colgate-Palmolive (India) Limited (NSE:COLPAL) Have The Makings Of Another Dividend Aristocrat?
Dec 22Is Now The Time To Put Colgate-Palmolive (India) (NSE:COLPAL) On Your Watchlist?
Dec 07How Much Of Colgate-Palmolive (India) Limited (NSE:COLPAL) Do Institutions Own?
Nov 22Is Colgate-Palmolive (India) Limited's (NSE:COLPAL) Latest Stock Performance Being Led By Its Strong Fundamentals?
Nov 07Colgate-Palmolive (India) Limited (NSE:COLPAL) Is About To Go Ex-Dividend, And It Pays A 2.5% Yield
Oct 23Should You Use Colgate-Palmolive (India)'s (NSE:COLPAL) Statutory Earnings To Analyse It?
Oct 22Did You Miss Colgate-Palmolive (India)'s (NSE:COLPAL) 58% Share Price Gain?
Oct 06Here's How We Evaluate Colgate-Palmolive (India) Limited's (NSE:COLPAL) Dividend
Sep 16Investors Interested In Colgate-Palmolive (India) Limited's (NSE:COLPAL) Earnings
Aug 29Should You Be Adding Colgate-Palmolive (India) (NSE:COLPAL) To Your Watchlist Today?
Aug 11What Kind Of Investors Own Most Of Colgate-Palmolive (India) Limited (NSE:COLPAL)?
Aug 11Colgate-Palmolive (India) Limited's (NSE:COLPAL) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jul 24Did Colgate-Palmolive (India)'s (NSE:COLPAL) Share Price Deserve to Gain 38%?
Jul 07Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 3/31/2027 | 75,483 | 18,925 | 19,274 | N/A | 18 |
| 3/31/2026 | 68,942 | 17,085 | 17,723 | N/A | 28 |
| 3/31/2025 | 62,934 | 15,365 | 15,210 | N/A | 28 |
| 6/30/2024 | 58,535 | 14,140 | N/A | N/A | N/A |
| 3/31/2024 | 56,804 | 13,237 | 11,234 | 11,990 | N/A |
| 12/31/2023 | 55,411 | 12,601 | N/A | N/A | N/A |
| 9/30/2023 | 54,367 | 11,732 | 12,576 | 13,355 | N/A |
| 6/30/2023 | 53,531 | 11,112 | N/A | N/A | N/A |
| 3/31/2023 | 52,262 | 10,471 | 11,062 | 11,763 | N/A |
| 12/31/2022 | 51,768 | 10,545 | N/A | N/A | N/A |
| 9/30/2022 | 51,657 | 10,636 | 11,391 | 11,870 | N/A |
| 6/30/2022 | 51,306 | 10,548 | N/A | N/A | N/A |
| 3/31/2022 | 50,998 | 10,783 | 15,761 | 16,257 | N/A |
| 12/31/2021 | 50,817 | 10,694 | N/A | N/A | N/A |
| 9/30/2021 | 50,335 | 10,654 | 10,928 | 11,730 | N/A |
| 6/30/2021 | 49,666 | 10,704 | N/A | N/A | N/A |
| 3/31/2021 | 48,412 | 10,354 | 7,261 | 7,839 | N/A |
| 12/31/2020 | 46,293 | 9,249 | N/A | N/A | N/A |
| 9/30/2020 | 45,445 | 8,756 | 10,506 | 10,969 | N/A |
| 6/30/2020 | 44,808 | 8,455 | N/A | N/A | N/A |
| 3/31/2020 | 45,251 | 8,165 | 8,692 | 9,296 | N/A |
| 12/31/2019 | 46,074 | 8,099 | N/A | N/A | N/A |
| 9/30/2019 | 45,598 | 8,029 | 7,685 | 8,697 | N/A |
| 6/30/2019 | 45,060 | 7,552 | N/A | N/A | N/A |
| 3/31/2019 | 44,624 | 7,756 | 8,442 | 9,830 | N/A |
| 12/31/2018 | 44,003 | 7,668 | N/A | N/A | N/A |
| 9/30/2018 | 43,343 | 7,453 | N/A | N/A | N/A |
| 6/30/2018 | 42,512 | 7,265 | N/A | N/A | N/A |
| 3/31/2018 | 41,880 | 6,734 | N/A | 6,939 | N/A |
| 12/31/2017 | 41,338 | 6,272 | N/A | N/A | N/A |
| 9/30/2017 | 39,751 | 5,844 | N/A | N/A | N/A |
| 6/30/2017 | 39,468 | 5,881 | N/A | N/A | N/A |
| 3/31/2017 | 39,818 | 5,774 | N/A | 6,880 | N/A |
| 12/31/2016 | 42,540 | 5,735 | N/A | N/A | N/A |
| 9/30/2016 | 43,362 | 6,108 | N/A | N/A | N/A |
| 6/30/2016 | 42,445 | 5,863 | N/A | N/A | N/A |
| 3/31/2016 | 38,682 | 5,812 | N/A | 6,887 | N/A |
| 12/31/2015 | 40,920 | 5,943 | N/A | N/A | N/A |
| 9/30/2015 | 40,731 | 5,657 | N/A | N/A | N/A |
| 6/30/2015 | 40,352 | 5,384 | N/A | N/A | N/A |
| 3/31/2015 | 39,819 | 5,590 | N/A | 6,382 | N/A |
| 12/31/2014 | 38,873 | 5,277 | N/A | N/A | N/A |
| 9/30/2014 | 37,827 | 5,096 | N/A | N/A | N/A |
| 6/30/2014 | 36,848 | 4,896 | N/A | N/A | N/A |
| 3/31/2014 | 35,788 | 5,399 | N/A | 4,574 | N/A |
| 12/31/2013 | 35,156 | 5,308 | N/A | N/A | N/A |
| 9/30/2013 | 33,943 | 5,290 | N/A | N/A | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: COLPALDas prognostizierte Gewinnwachstum (9.2% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: COLPALDie Erträge des Unternehmens (9.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Indian (16% pro Jahr).
Hohe Wachstumserträge: COLPALDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: COLPALDie Einnahmen des Unternehmens (7.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Indian (9.6% pro Jahr).
Hohe Wachstumseinnahmen: COLPALDie Einnahmen des Unternehmens (7.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: COLPALDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (86%).